Clinical Trial Update: Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 dose-escalation trial of palifermin in pediatric participants undergoing allogeneic hematopoietic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Oral Mucositis

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Oral Mucositis, Hematopoietic Stem Cell Transplantation | Phase 1 | Status: COMPLETED